|Bid||0.00 x 1100|
|Ask||0.00 x 1000|
|Day's Range||169.80 - 185.59|
|52 Week Range||122.35 - 224.95|
|Beta (3Y Monthly)||-0.03|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 5, 2018 - Nov 9, 2018|
|Forward Dividend & Yield||0.64 (0.35%)|
|1y Target Est||240.00|
NEW YORK, Oct. 22, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
If you want to know who really controls Mesa Laboratories Inc (NASDAQ:MLAB), then you’ll have to look at the makeup of its share registry. Institutions often own shares in more Read More...
Lakewood, Colo., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 17, 2018, to shareholders of record at the close of business on November 30, 2018. Mesa is a global technology innovator committed to solving some of the most critical quality control and analytical challenges in the pharmaceutical, healthcare, industrial safety, environmental and food & beverage industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Instruments, Cold Chain Monitoring and Cold Chain Packaging) which help its customers ensure product integrity, increase patient and worker safety, and design innovative solutions that improve the quality of life throughout the world.
Mesa Laboratories, Inc. (MLAB) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
The Lakewood, Colorado-based company said it had profit of $1.06 per share. Earnings, adjusted for amortization costs and stock option expense, were $1.84 per share. The quality control instruments and ...
LAKEWOOD, Colo., July 31, 2018-- Mesa Laboratories, Inc. today reported record first quarter revenues and net income for the three months ended June 30, 2018.. Highlights for the quarter ended June 30, ...
On a per-share basis, the Lakewood, Colorado-based company said it had net income of $1.08. Earnings, adjusted for non-recurring costs and amortization costs, came to $2.23 per share. The quality control ...
When Mesa Laboratories Inc (NASDAQ:MLAB) released its most recent earnings update (31 December 2017), I wanted to understand how these figures stacked up against its past performance. The two benchmarksRead More...
Does the share price for Mesa Laboratories Inc (NASDAQ:MLAB) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value using the discounted cash flow (DCF) method. Anyone interestedRead More...
On a per-share basis, the Lakewood, Colorado-based company said it had a loss of $2.93. Losses, adjusted for asset impairment costs and non-recurring costs, were 24 cents per share. The quality control ...
Investors are always looking for growth in small-cap stocks like Mesa Laboratories Inc (NASDAQ:MLAB), with a market cap of $487.81M. However, an important fact which most ignore is: how financiallyRead More...
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Mesa Laboratories, Inc. with the following peers – Cantel Medical Corp., Thermo Fisher Scientific Inc., Harvard Bioscience, Inc., AMETEK, Inc., STERIS Plc, 3M Company, AngioDynamics, Inc., Bruker Corporation, Rockwell Medical, Inc. and Danaher Corporation (CMD-US, TMO-US, HBIO-US, AME-US, STE-US, MMM-US, ANGO-US, BRKR-US, RMTI-US and DHR-US). ... Read more (Read more...)